Release Date: 30/04/13 11:45 Summary: Quarterly Activities Report and Cash Flows Price Sensitive: Yes Download Document 890.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%